Cencora EBITDA 2010-2025 | COR
- Cencora EBITDA for the quarter ending March 31, 2025 was $1.300B, a 56.08% increase year-over-year.
- Cencora EBITDA for the twelve months ending March 31, 2025 was $3.648B, a 0.15% increase year-over-year.
- Cencora 2024 annual EBITDA was $3.294B, a 0.83% decline from 2023.
- Cencora 2023 annual EBITDA was $3.322B, a 7.98% increase from 2022.
- Cencora 2022 annual EBITDA was $3.076B, a 6.05% increase from 2021.
Cencora Annual EBITDA (Millions of US $) |
|
---|---|
2024 | $3,294 |
2023 | $3,322 |
2022 | $3,076 |
2021 | $2,901 |
2020 | $-4,366 |
2019 | $1,609 |
2018 | $2,013 |
2017 | $1,493 |
2016 | $1,918 |
2015 | $678 |
2014 | $979 |
2013 | $1,069 |
2012 | $1,444 |
2011 | $1,296 |
2010 | $1,181 |
2009 | $978 |
Cencora Quarterly EBITDA (Millions of US $) |
|
---|---|
2025-03-31 | $1,300 |
2024-12-31 | $988 |
2024-09-30 | $406 |
2024-06-30 | $953 |
2024-03-31 | $833 |
2023-12-31 | $1,101 |
2023-09-30 | $761 |
2023-06-30 | $947 |
2023-03-31 | $805 |
2022-12-31 | $809 |
2022-09-30 | $629 |
2022-06-30 | $663 |
2022-03-31 | $960 |
2021-12-31 | $825 |
2021-09-30 | $768 |
2021-06-30 | $752 |
2021-03-31 | $729 |
2020-12-31 | $652 |
2020-09-30 | $-5,652 |
2020-06-30 | $504 |
2020-03-31 | $410 |
2019-12-31 | $373 |
2019-09-30 | $293 |
2019-06-30 | $519 |
2019-03-31 | $184 |
2018-12-31 | $613 |
2018-09-30 | $341 |
2018-06-30 | $535 |
2018-03-31 | $607 |
2017-12-31 | $531 |
2017-09-30 | $-23 |
2017-06-30 | $278 |
2017-03-31 | $731 |
2016-12-31 | $506 |
2016-09-30 | $328 |
2016-06-30 | $629 |
2016-03-31 | $1,050 |
2015-12-31 | $-89 |
2015-09-30 | $620 |
2015-06-30 | $403 |
2015-03-31 | $-308 |
2014-12-31 | $-37 |
2014-09-30 | $266 |
2014-06-30 | $160 |
2014-03-31 | $347 |
2013-12-31 | $205 |
2013-09-30 | $158 |
2013-06-30 | $178 |
2013-03-31 | $392 |
2012-12-31 | $341 |
2012-09-30 | $361 |
2012-06-30 | $361 |
2012-03-31 | $409 |
2011-12-31 | $313 |
2011-09-30 | $245 |
2011-06-30 | $349 |
2011-03-31 | $396 |
2010-12-31 | $307 |
2010-09-30 | $250 |
2010-06-30 | $308 |
2010-03-31 | $336 |
2009-12-31 | $288 |
2009-09-30 | $250 |
2009-06-30 | $237 |
2009-03-31 | $271 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $56.278B | $293.959B |
CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $147.134B | 27.29 |
CVS Health (CVS) | United States | $76.787B | 9.54 |
Elevance Health (ELV) | United States | $65.099B | 8.76 |
DiDi Global (DIDIY) | China | $25.745B | 27.35 |
Labcorp Holdings (LH) | United States | $22.177B | 17.50 |
Natera (NTRA) | United States | $18.966B | 0.00 |
BioMerieux (BMXMF) | France | $17.681B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $15.851B | 0.00 |
ICON (ICLR) | Ireland | $15.102B | 14.53 |
CochLear (CHEOY) | Australia | $13.402B | 0.00 |
Solventum (SOLV) | United States | $12.933B | 13.69 |
Medpace Holdings (MEDP) | United States | $12.571B | 33.27 |
Revvity (RVTY) | United States | $12.220B | 21.03 |
Viatris (VTRS) | United States | $11.044B | 3.79 |
Avantor (AVTR) | United States | $9.683B | 14.07 |
Sonic Healthcare (SKHHY) | Australia | $9.143B | 0.00 |
Charles River Laboratories (CRL) | United States | $8.690B | 17.03 |
HealthEquity (HQY) | United States | $8.305B | 36.38 |
Caris Life Sciences,�Inc (CAI) | United States | $7.515B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
Bausch + Lomb (BLCO) | Canada | $5.066B | 29.83 |
BrightSpring Health Services (BTSG) | United States | $3.609B | 33.11 |
Sotera Health (SHC) | United States | $3.491B | 19.84 |
Surgery Partners (SGRY) | United States | $2.725B | 35.43 |
Organon (OGN) | United States | $2.654B | 2.82 |
Concentras Parent (CON) | United States | $2.520B | 14.56 |
Alignment Healthcare (ALHC) | United States | $2.327B | 0.00 |
GeneDx Holdings (WGS) | United States | $2.278B | 87.73 |
Progyny (PGNY) | United States | $1.981B | 43.60 |
GoodRx Holdings (GDRX) | United States | $1.786B | 35.71 |
PACS (PACS) | United States | $1.782B | 0.00 |
Premier (PINC) | United States | $1.744B | 13.23 |
Ardent Health (ARDT) | United States | $1.582B | 6.74 |
Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.226B | 0.00 | |
Pediatrix Medical (MD) | United States | $1.080B | 8.22 |
QDM (QDMI) | Hong Kong, SAR China | $0.997B | 342.00 |
Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
Agilon Health (AGL) | United States | $0.853B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.758B | 7.10 |
CareDx (CDNA) | United States | $0.712B | 11.12 |
Embecta (EMBC) | United States | $0.686B | 4.62 |
Nutex Health (NUTX) | United States | $0.528B | 7.99 |
InnovAge Holding (INNV) | United States | $0.518B | 0.00 |
Omada Health (OMDA) | $0.495B | 0.00 | |
SBC Medicals (SBC) | United States | $0.493B | 0.00 |
LifeMD (LFMD) | United States | $0.486B | 0.00 |
So-Young (SY) | China | $0.471B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.464B | 10.45 |
Sonida Senior Living (SNDA) | United States | $0.461B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.405B | 0.00 |
Enhabit (EHAB) | United States | $0.342B | 28.12 |
Oncology Institute (TOI) | United States | $0.328B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.284B | 0.00 |
Beauty Health (SKIN) | United States | $0.226B | 0.00 |
Pheton Holdings (PTHL) | China | $0.192B | 0.00 |
DocGo (DCGO) | United States | $0.149B | 24.33 |
Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.090B | 0.00 |
KindlyMD (NAKA) | United States | $0.080B | 0.00 |
Biodesix (BDSX) | United States | $0.065B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.063B | 0.00 |
NeueHealth (NEUE) | United States | $0.060B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
ModivCare (MODV) | United States | $0.044B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.042B | 0.00 |
OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.006B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
INVO Fertility (IVF) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |